Pivotal ADC approval trials in gynecologic cancers disproportionately enrolled White, younger, fitter, less-pretreated patients, limiting generalizability to routine oncology practice. Real-world ...
Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy that combines the precision of monoclonal antibodies with the potency of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results